论文部分内容阅读
为了探讨鲁米那治疗早产儿颅内出血的临床价值，对３７例生活力低下的住院早产儿随机分为２组进行对照研究。治疗组２４例静脉注射鲁米那，发生颅内出血１０例，出血校正率４１．６％，死亡３例；对照组１３例行常规治疗，发生颅内出血５例，出血校正率４０．０％，死亡５例。统计学处理，显示两组出血发生率差别无显著性意义（Ｐ＞０．０５）。死亡率差别有显著性意义（Ｐ＜０．０５）。疗效表明鲁米那不能降低早产儿颅内出血发生率，有降低其死亡率，减轻颅内出血严重程度的倾向。
In order to investigate the clinical value of luminal in the treatment of intracranial hemorrhage in preterm infants, 37 infants with low viability were randomly divided into two groups. In the treatment group, 24 cases received intravenous injection of luminal, 10 cases developed intracranial hemorrhage, the hemorrhage correction rate was 41.6% and the death was 3 cases. In the control group, 13 cases were treated routinely with intracranial hemorrhage in 5 cases and the hemorrhage correction rate was 40.0% 5 died. Statistical analysis showed no significant difference between the two groups in the incidence of hemorrhage (P> 0.05). The difference in mortality was significant (P <0.05). Efficacy of luminal that can not reduce the incidence of intracranial hemorrhage in preterm children, reduce their mortality, reduce the severity of intracranial hemorrhage tendency.